Real-World Study of PADN for the Treatment of PAH
Recruiting
Observational Study
Pulmonary Hypertension
Hypertension, Pulmonary Arterial
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Pulnovo Medical (Wuxi) Co., Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Real-World Study of PADN for the Treatment of PAH
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Diagnosed with PAH and received PADN procedure since March 2024.
2. No contraindications to procedure.
3. Able to provide informed consent and authorize use of health/research data.
4. Compliant with treatment and follow-up requirements.
Exclusion Criteria:
None specified.
Contacts
No contact information available.